Trump Orders Pharmaceutical Firms to Lower US Drug Prices

Donald Trump signed an executive order yesterday, directing drug makers to lower the prices of their medicines to align with what other countries pay. The order, which gives companies 30 days to cut the cost of prescription drugs in the US or face new limits on what the government will pay, aims to reduce the high prices of medications in America. Trump claimed that Europeans will have to pay more for healthcare, while Americans will pay less, following his administration's decision to tie US drug prices to those paid by other countries. The President cited the example of a common asthma drug costing less than $40 in the UK but $500 in America, and a "fat drug" that costs $88 in London but $1,300 in New York.

Key Takeaways:

• The executive order requires pharmaceutical companies to lower US drug prices to match prices paid by other countries within 30 days or face new limits on government payments.
• The order aims to reduce the high prices of medications in America, with President Trump citing examples of drugs costing significantly more in the US compared to other countries.
• The move has been met with opposition from the pharmaceutical lobby, which argues that lower prices would jeopardise research into new drugs and investments in the US by pharmaceutical companies.
• Trump claimed that the change would result in Europeans paying more for healthcare, while Americans would pay less, with the goal of creating a more equitable pricing system.
• The President acknowledged that some EU countries, including the UK, pay significantly lower prices for the same medications, with the asthma drug example costing less than $40 in the UK but $500 in America.
• The US health department will broker new price tags for drugs, and if a deal is not reached, a rule will kick in that ties the price of what the US pays for medications to lower prices paid by other countries.

Statistics:

• $500: the cost in the US of a common asthma drug that costs less than $40 in the UK.
• $40: the cost in the UK of a common asthma drug that costs $500 in the US.
• $88: the cost in London of a "fat drug" that costs $1,300 in New York.
• $1,300: the cost in New York of a "fat drug" that costs $88 in London.
• 30 days: the time given to pharmaceutical companies to lower US drug prices in line with other countries.
• hundreds of billions: the amount of investment planned by pharmaceutical companies in the US, according to PhRMA.

Sources:

• Trump, D. (2023). Quote, no exact date mentioned. Source: White House.
• Trump, D. (2023). Quote, no exact date mentioned. Source: White House.
• Ubl, S. J. (2023). Quote, no exact date mentioned. Source: PhRMA.